UniXell’s FDA clearance advances Parkinson’s cell therapy

Chinese biotech wins US approval to test an off-the-shelf stem cell therapy, bringing scalable regenerative medicine one step closer. Stem cell therapies have never lacked ambition; their biggest obstacle has always been trust. One concern has overshadowed the field: what happens after the cells are transplanted? If replacement cells continue multiplying uncontrollably, they could form […] The post UniXell’s FDA clearance advances Parkinson’s cell therapy appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.